UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Total homocysteine increases risk of cerebral infarction’
Researchers at Seoul National University Boramea Hospital have discovered t...
by Lee Han-soo
|
2019-02-08 16:13
라인
Pangen wins Malaysia’s nod for epoetin alfa biosimilar
Pangen said Thursday that Malaysia’s National Pharmaceutical Regulatory Age...
by Lee Han-soo
|
2019-02-08 16:13
라인
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea
Sanofi is preparing to seek an additional indication of Praluent (alirocuma...
by Kim Yun-mi
|
2019-02-08 16:12
라인
Multinationals prepare next-generation pneumococcal vaccines
Multinational pharmaceutical firms are gearing up to replace conventional p...
by Kim Yun-mi
|
2019-02-08 12:02
라인
Kainos Medicine starts developing treatment for multiple system atrophy
Kainos Medicine said Friday that it would develop a treatment for multiple ...
by Lee Han-soo
|
2019-02-08 11:47
라인
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’
Novartis said Thursday that Cosentyx (Ingredient: secukinumab), its interle...
by Lee Han-soo
|
2019-02-07 17:14
라인
Seoul accepts Bayer’s request to reduce study subjects of cancer drug
The government has accepted Bayer’s request to reduce the number of review ...
by Lee Hye-seon
|
2019-02-07 16:06
라인
FDA starts inspecting SK Biopharm’s epilepsy treatment
SK Biopharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Lee Han-soo
|
2019-02-07 16:01
라인
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo
|
2019-02-07 14:40
라인
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi
|
2019-02-07 14:40
라인
Korean firms ink $232 million surgical device export deals in Dubai
Korean medical device makers showcased an integrated showroom of surgical d...
by Park Gi-taek
|
2019-02-07 11:55
라인
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo
|
2019-02-07 11:09
라인
EM physician from Korea enjoys work-life balance in America
She had a solid reason to live as a doctor in the United States: She wanted...
by Song Soo-youn
|
2019-02-06 06:00
라인
[Special] Why did these med students become YouTubers?
People today are living in an era of YouTube. It exerts enormous influence ...
by Cho In-sung
|
2019-02-05 07:27
라인
[Special] Nearly one-third of children under 5 suffer from chronic malnutrition
It is lunchtime and children rushed seemingly from nowhere. The cafeteria t...
by Yoon Won-sub
|
2019-02-04 06:00
라인
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo
|
2019-02-01 17:04
라인
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease
Novartis Korea’s dementia treatment Exelon (rivastigmine) obtained expanded...
by Kim Yun-mi
|
2019-02-01 17:02
라인
‘Alunbrig works better for ALK-positive non-small cell lung cancer’
Second-line treatment options are increasing for patients with anaplastic l...
by Kim Yun-mi
|
2019-02-01 15:38
라인
Medytox, Daewoong continue to squabble over BTX
A heated debate is continuing between Medytox and Daewoong Pharmaceuticals ...
by Lee Han-soo
|
2019-02-01 15:36
라인
Samsung BioLogics posts ₩535.8 billion in 2018 sales
Samsung BioLogics said Thursday that it recorded 535.8 billion won ($479 mi...
by Lee Han-soo
|
2019-02-01 11:56
-
이전
141
142
143
144
145
146
147
148
149
150
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top